Urgent.News

What's breaking now, across thousands of outlets.

AI

AMD deepens AI inference bet with Taalas deal as chip race heats up

Toronto-based Taalas develops specialized silicon designed to reduce computing and memory bottlenecks in AI inference, the process of running trained AI models to generate responses or predictions.

AMD deepens AI inference bet with Taalas deal as chip race heats up

AMD has acquired Toronto-based Taalas, a company that develops specialized silicon for AI inference. Taalas' approach involves integrating model weights directly into silicon, which promises to boost inference performance by an order of magnitude or more. According to The Register, this is an actual acquisition rather than an acquihire, although the terms of the deal were not disclosed.

Taalas' chips, described as model-specific integrated circuits, do not rely on high-bandwidth memory to store model weights. Instead, they etch the weights directly into the silicon. The company's first test chip, the HC1, was fabbed on TSMC's 6nm process tech and showed impressive performance in initial benchmarks. Specifically, The Register and The Register Science reported that the HC1 served Meta's Llama 3.1 8B at 16,960 tokens a second.

The acquisition is seen as part of AMD's bid to challenge Nvidia's dominance in AI hardware. As The Register noted, the deal is similar in context to Nvidia's $20 billion licensing deal with Groq last December, aiming to make high-performance "premium" inference services faster and cheaper to run.

Brief written by urgent.news from Economic Times Tech, Hacker News Best, Techmeme, The Register, The Register Science — 5 reports on this story. Machine-written — may contain errors; check the original before relying on it.

This story

This is one outlet's version. Read the fullest account.

Read the original at economictimes.indiatimes.com →

More in AI

Scientists Make First Viruses Designed By AI

An anonymous reader quotes a report from The Guardian: Scientists have made the first viruses designed by artificial intelligence in a milestone that raises hopes for new medicines but also concerns…

  • Scientists create first AI-designed viruses (bacteriophages) for targeted bacterial treatment.
  • Genome language models used to design functioning bacteriophage genomes in lab.
  • Researchers emphasize biosafety, biocontainment, and biosecurity in AI-generated virus development.

More from Friday 7 August →